APA (7th ed.) Citation

Boufker, H. I., Lagneaux, L., Najar, M., Piccart, M., Ghanem, G., Body, J., & Journé, F. Editorial Expression of Concern: The Src inhibitor dasatinib accelerates the differentiation of human bone marrow-derived mesenchymal stromal cells into osteoblasts. BMC.

Chicago Style (17th ed.) Citation

Boufker, Hichame Id, Laurence Lagneaux, Mehdi Najar, Martine Piccart, Ghanem Ghanem, Jean-Jacques Body, and Fabrice Journé. Editorial Expression of Concern: The Src Inhibitor Dasatinib Accelerates the Differentiation of Human Bone Marrow-derived Mesenchymal Stromal Cells into Osteoblasts. BMC.

MLA (9th ed.) Citation

Boufker, Hichame Id, et al. Editorial Expression of Concern: The Src Inhibitor Dasatinib Accelerates the Differentiation of Human Bone Marrow-derived Mesenchymal Stromal Cells into Osteoblasts. BMC.